These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 20298986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
    Shi YJ, Lv J, Han XT, Luo GG.
    BMC Cardiovasc Disord; 2017 Jul 26; 17(1):203. PubMed ID: 28747203
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Praz F, Tai T, Findling O, Walpoth N, Nedeltchev K, Schwerzmann M, Windecker S, Mattle HP, Meier B.
    Heart; 2010 Jun 26; 96(12):967-73. PubMed ID: 20538672
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder.
    Luc JGY, Bakar SN, Kiaii B, Sridhar K.
    JACC Cardiovasc Interv; 2018 Jun 11; 11(11):1108-1109. PubMed ID: 29778728
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract] [Full Text] [Related]

  • 13. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M, Banerjee S, Brilakis ES.
    Cardiovasc Revasc Med; 2010 Dec 01; 11(1):63-6. PubMed ID: 20129363
    [Abstract] [Full Text] [Related]

  • 14. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):390-5. PubMed ID: 18288745
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
    Mojadidi MK, Elgendy AY, Elgendy IY, Mahmoud AN, Elbadawi A, Eshtehardi P, Patel NK, Wayangankar S, Tobis JM, Meier B.
    JACC Cardiovasc Interv; 2017 Nov 13; 10(21):2228-2230. PubMed ID: 29122137
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
    Rudolph V, Augustin J, Hofmann T, Hamm CW, Meinertz T, Köster R, Baldus S, Franzen O.
    EuroIntervention; 2014 Nov 13; 9(12):1418-22. PubMed ID: 24169021
    [Abstract] [Full Text] [Related]

  • 20. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache.
    Khessali H, Mojadidi MK, Gevorgyan R, Levinson R, Tobis J.
    JACC Cardiovasc Interv; 2012 Jun 13; 5(6):682-7. PubMed ID: 22721665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.